DOCSLIB.ORG

Zoonoses and Communicable Diseases Common to Man and Animals

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Zoonoses and Communicable Diseases Common to Man and Animals ZOONOSES AND COMMUNICABLE DISEASES COMMON TO MAN AND ANIMALS Third Edition Volume I Bacterioses and Mycoses Scientific and Technical Publication No. 580 PAN AMERICAN HEALTH ORGANIZATION Pan American Sanitary Bureau, Regional Office of the WORLD HEALTH ORGANIZATION 525 Twenty-third Street, N.W. Washington, D.C. 20037 U.S.A. 2001 Also published in Spanish (2001) with the title: Zoonosis y enfermedades transmisibles comunes al hombre a los animales ISBN 92 75 31580 9 PAHO Cataloguing-in-Publication Pan American Health Organization Zoonoses and communicable diseases common to man and animals 3rd ed. Washington, D.C.: PAHO, © 2001. 3 vol.—(Scientific and Technical Publication No. 580) ISBN 92 75 11580 X I. Title II. Series 1. ZOONOSES 2. BACTERIAL INFECTIONS AND MYCOSES 3. COMMUNICABLE DISEASE CONTROL 4. FOOD CONTAMINATION 5. PUBLIC HEALTH VETERINARY 6. DISEASE RESERVOIRS NLM WC950.P187 2001 En The Pan American Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and inquiries should be addressed to the Publications Program, Pan American Health Organization, Washington, D.C., U.S.A., which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available. ©Pan American Health Organization, 2001 Publications of the Pan American Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights are reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the Pan American Health Organization concerning the status of any country, ter- ritory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the Pan American Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. CONTENTS Prologue . vii Preface to the First Edition . ix Preface to the Second Edition . xi Introduction . xv PART I: BACTERIOSES Actinomycosis . 3 Aeromoniasis. 6 Animal Erysipelas and Human Erysipeloid . 14 Anthrax . 21 Botulism . 28 Brucellosis. 40 Campylobacteriosis . 67 Cat-scratch Disease . 78 Clostridial Food Poisoning. 82 Clostridial Wound Infections . 87 Colibacillosis. 90 Corynebacteriosis . 99 Dermatophilosis. 103 Diseases Caused by Nontuberculous Mycobacteria . 107 Diseases in Man and Animals Caused by Non-O1 Vibrio cholerae. 117 Enterocolitic Yersiniosis. 122 Enterocolitis Due to Clostridium difficile . 132 Food Poisoning Caused by Vibrio parahaemolyticus . 138 Glanders . 142 Infection Caused by Capnocytophaga canimorsus and C. cynodegmi. 146 Leprosy . 149 Leptospirosis . 157 Listeriosis . 168 Lyme Disease . 179 Melioidosis . 184 Necrobacillosis . 190 Nocardiosis . 195 Pasteurellosis . 199 Plague . 207 Pseudotuberculous Yersiniosis . 218 Rat-bite Fever . 226 Rhodococcosis. 229 Salmonellosis. 233 Shigellosis . 247 Staphylococcal Food Poisoning . 251 Streptococcosis . 257 Tetanus . 265 Tick-borne Relapsing Fever . 271 iii iv CONTENTS Tularemia . 275 Zoonotic Tuberculosis . 283 PART II: MYCOSES Adiaspiromycosis . 303 Aspergillosis . 305 Blastomycosis . 311 Candidiasis . 315 Coccidioidomycosis. 320 Cryptococcosis . 326 Dermatophytosis . 332 Histoplasmosis. 339 Mycetoma . 345 Protothecosis . 348 Rhinosporidiosis . 350 Sporotrichosis . 352 Zygomycosis . 356 Index . 361 LIST OF TABLES AND ILLUSTRATIONS Bacterioses Tables 1. Foods giving rise to botulism, and number of outbreaks, United States of America, 1899–1977 . 31 2. Number of cases and deaths from human plague in the Americas, 1971–1980 . 210 3. Outbreaks of foodborne salmonellosis in selected countries, 1981–1985 . 235 4. Distribution of tetanus morbidity according to political division and climate, Argentina, 1967–1977 . 267 Figures 1. Animal erysipelas and human erysipeloid (Erysipelothrix rhusiopathiae). Mode of transmission . 17 2. Anthrax. Transmission cycle . 25 3. Botulism (transmitted by foods). Reported cases and deaths per year, United States of America, 1960–1980 . 29 4. Reported cases of botulism per year, Argentina, 1967–1981 . 32 5. Bovine brucellosis (Brucella abortus). Mode of transmission . 52 6. Swine brucellosis (Brucella suis). Mode of transmission . 53 CONTENTS v 7. Caprine and ovine brucellosis (Brucella melitensis). Mode of transmission . 54 8. Campylobacteriosis (Campylobacter jejuni). Mode of transmission. 70 9. Campylobacteriosis (Campylobacter fetus). Probable mode of transmission . 75 10. Enterocolitic yersiniosis (Yersinia enterocolitica). Supposed mode of transmission . ..
Load more

Recommended publications
  • Official Nh Dhhs Health Alert
    THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network [email protected] May 18, 2018, 1300 EDT (1:00 PM EDT) NH-HAN 20180518 Tickborne Diseases in New Hampshire Key Points and Recommendations: 1. Blacklegged ticks transmit at least five different infections in New Hampshire (NH): Lyme disease, Anaplasma, Babesia, Powassan virus, and Borrelia miyamotoi. 2. NH has one of the highest rates of Lyme disease in the nation, and 50-60% of blacklegged ticks sampled from across NH have been found to be infected with Borrelia burgdorferi, the bacterium that causes Lyme disease. 3. NH has experienced a significant increase in human cases of anaplasmosis, with cases more than doubling from 2016 to 2017. The reason for the increase is unknown at this time. 4. The number of new cases of babesiosis also increased in 2017; because Babesia can be transmitted through blood transfusions in addition to tick bites, providers should ask patients with suspected babesiosis whether they have donated blood or received a blood transfusion. 5. Powassan is a newer tickborne disease which has been identified in three NH residents during past seasons in 2013, 2016 and 2017. While uncommon, Powassan can cause a debilitating neurological illness, so providers should maintain an index of suspicion for patients presenting with an unexplained meningoencephalitis. 6. Borrelia miyamotoi infection usually presents with a nonspecific febrile illness similar to other tickborne diseases like anaplasmosis, and has recently been identified in one NH resident. Tests for Lyme disease do not reliably detect Borrelia miyamotoi, so providers should consider specific testing for Borrelia miyamotoi (see Attachment 1) and other pathogens if testing for Lyme disease is negative but a tickborne disease is still suspected.
    [Show full text]
  • Plague Manual for Investigation
    Plague Summary Plague is a flea-transmitted bacterial infection of rodents caused by Yersinia pestis. Fleas incidentally transmit the infection to humans and other susceptible mammalian hosts. Humans may also contract the disease from direct contact with an infected animal. The most common clinical form is acute regional lymphadenitis, called bubonic plague. Less common clinical forms include septicemic, pneumonic, and meningeal plague. Pneumonic plague can be spread from person to person via airborne transmission, potentially leading to epidemics of primary pneumonic plague. Plague is immediately reportable to the New Mexico Department of Health. Plague is treatable with antibiotics, but has a high fatality rate with inadequate or delayed treatment. Plague preventive measures include: isolation of pneumonic plague patients; prophylactic treatment of pneumonic case contacts; avoiding contact with rodents and their fleas; reducing rodent harborage around the home; using flea control on pets; and, preventing pets from hunting. Agent Plague is caused by Yersinia pestis, a gram-negative, bi-polar staining, non-motile, non-spore forming coccobacillus. Transmission Reservoir: Wild rodents (especially ground squirrels) are the natural vertebrate reservoir of plague. Lagomorphs (rabbits and hares), wild carnivores, and domestic cats may also be a source of infection to humans. Vector: In New Mexico, the rock squirrel flea, Oropsylla montana, is the most important vector of plague for humans. Many more flea species are involved in the transmission of sylvatic (wildlife) plague. Mode of Transmission: Most humans acquire plague through the bites of infected fleas. Fleas can be carried into the home by pet dogs and cats, and may be abundant in woodpiles or burrows where peridomestic rodents such as rock squirrels (Spermophilus variegatus) have succumbed to plague infection.
    [Show full text]
  • Amerithrax Investigative Summary
    The United States Department of Justice AMERITHRAX INVESTIGATIVE SUMMARY Released Pursuant to the Freedom of Information Act Friday, February 19, 2010 TABLE OF CONTENTS I. THE ANTHRAX LETTER ATTACKS . .1 II. EXECUTIVE SUMMARY . 4 A. Overview of the Amerithrax Investigation . .4 B. The Elimination of Dr. Steven J. Hatfill as a Suspect . .6 C. Summary of the Investigation of Dr. Bruce E. Ivins . 6 D. Summary of Evidence from the Investigation Implicating Dr. Ivins . .8 III. THE AMERITHRAX INVESTIGATION . 11 A. Introduction . .11 B. The Investigation Prior to the Scientific Conclusions in 2007 . 12 1. Early investigation of the letters and envelopes . .12 2. Preliminary scientific testing of the Bacillus anthracis spore powder . .13 3. Early scientific findings and conclusions . .14 4. Continuing investigative efforts . 16 5. Assessing individual suspects . .17 6. Dr. Steven J. Hatfill . .19 7. Simultaneous investigative initiatives . .21 C. The Genetic Analysis . .23 IV. THE EVIDENCE AGAINST DR. BRUCE E. IVINS . 25 A. Introduction . .25 B. Background of Dr. Ivins . .25 C. Opportunity, Access and Ability . 26 1. The creation of RMR-1029 – Dr. Ivins’s flask . .26 2. RMR-1029 is the source of the murder weapon . 28 3. Dr. Ivins’s suspicious lab hours just before each mailing . .29 4. Others with access to RMR-1029 have been ruled out . .33 5. Dr. Ivins’s considerable skill and familiarity with the necessary equipment . 36 D. Motive . .38 1. Dr. Ivins’s life’s work appeared destined for failure, absent an unexpected event . .39 2. Dr. Ivins was being subjected to increasing public criticism for his work .
    [Show full text]
  • Investigation of Anthrax Associated with Intentional Exposure
    October 19, 2001 / Vol. 50 / No. 41 889 Update: Investigation of Anthrax Associated with Intentional Exposure and Interim Public Health Guidelines, October 2001 893 Recognition of Illness Associated with the Intentional Release of a Biologic Agent 897 Weekly Update: West Nile Virus Activity — United States, October 10–16, 2001 Update: Investigation of Anthrax Associated with Intentional Exposure and Interim Public Health Guidelines, October 2001 On October 4, 2001, CDC and state and local public health authorities reported a case of inhalational anthrax in Florida (1 ). Additional cases of anthrax subsequently have been reported from Florida and New York City. This report updates the findings of these case investigations, which indicate that infections were caused by the intentional release of Bacillus anthracis. This report also includes interim guidelines for postexposure pro- phylaxis for prevention of inhalational anthrax and other information to assist epidemi- ologists, clinicians, and laboratorians responding to intentional anthrax exposures. For these investigations, a confirmed case of anthrax was defined as 1) a clinically compatible case of cutaneous, inhalational, or gastrointestinal illness* that is laboratory confirmed by isolation of B. anthracis from an affected tissue or site or 2) other labora- tory evidence of B. anthracis infection based on at least two supportive laboratory tests. A suspected case was defined as 1) a clinically compatible case of illness without isola- tion of B. anthracis and no alternative diagnosis, but with laboratory evidence of B. anthracis by one supportive laboratory test or 2) a clinically compatible case of an- thrax epidemiologically linked to a confirmed environmental exposure, but without cor- roborative laboratory evidence of B.
    [Show full text]
  • Naeglaria and Brain Infections
    Can bacteria shrink tumors? Cancer Therapy: The Microbial Approach n this age of advanced injected live Streptococcus medical science and into cancer patients but after I technology, we still the recipients unfortunately continue to hunt for died from subsequent innovative cancer therapies infections, Coley decided to that prove effective and safe. use heat killed bacteria. He Treatments that successfully made a mixture of two heat- eradicate tumors while at the killed bacterial species, By Alan Barajas same time cause as little Streptococcus pyogenes and damage as possible to normal Serratia marcescens. This Alani Barajas is a Research and tissue are the ultimate goal, concoction was termed Development Technician at Hardy but are also not easy to find. “Coley’s toxins.” Bacteria Diagnostics. She earned her bachelor's degree in Microbiology at were either injected into Cal Poly, San Luis Obispo. The use of microorganisms in tumors or into the cancer therapy is not a new bloodstream. During her studies at Cal Poly, much idea but it is currently a of her time was spent as part of the undergraduate research team for the buzzing topic in cancer Cal Poly Dairy Products Technology therapy research. Center studying spore-forming bacteria in dairy products. In the late 1800s, German Currently she is working on new physicians W. Busch and F. chromogenic media formulations for Fehleisen both individually Hardy Diagnostics, both in the observed that certain cancers prepared and powdered forms. began to regress when patients acquired accidental erysipelas (cellulitis) caused by Streptococcus pyogenes. William Coley was the first to use New York surgeon William bacterial injections to treat cancer www.HardyDiagnostics.com patients.
    [Show full text]
  • REALM Research Briefing: Vaccines, Variants, and Venitlation
    Briefing: Vaccines, Variants, and Ventilation A Briefing on Recent Scientific Literature Focused on SARS-CoV-2 Vaccines and Variants, Plus the Effects of Ventilation on Virus Spread Dates of Search: 01 January 2021 through 05 July 2021 Published: 22 July 2021 This document synthesizes various studies and data; however, the scientific understanding regarding COVID-19 is continuously evolving. This material is being provided for informational purposes only, and readers are encouraged to review federal, state, tribal, territorial, and local guidance. The authors, sponsors, and researchers are not liable for any damages resulting from use, misuse, or reliance upon this information, or any errors or omissions herein. INTRODUCTION Purpose of This Briefing • Access to the latest scientific research is critical as libraries, archives, and museums (LAMs) work to sustain modified operations during the continuing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. • As an emerging event, the SARS-CoV-2 pandemic continually presents new challenges and scientific questions. At present, SARS-CoV-2 vaccines and variants in the US are two critical areas of focus. The effects of ventilation-based interventions on the spread of SARS-CoV-2 are also an interest area for LAMs. This briefing provides key information and results from the latest scientific literature to help inform LAMs making decisions related to these topics. How to Use This Briefing: This briefing is intended to provide timely information about SARS-CoV-2 vaccines, variants, and ventilation to LAMs and their stakeholders. Due to the evolving nature of scientific research on these topics, the information provided here is not intended to be comprehensive or final.
    [Show full text]
  • Reportable Diseases and Conditions
    KINGS COUNTY DEPARTMENT of PUBLIC HEALTH 330 CAMPUS DRIVE, HANFORD, CA 93230 REPORTABLE DISEASES AND CONDITIONS Title 17, California Code of Regulations, §2500, requires that known or suspected cases of any of the diseases or conditions listed below are to be reported to the local health jurisdiction within the specified time frame: REPORT IMMEDIATELY BY PHONE During Business Hours: (559) 852-2579 After Hours: (559) 852-2720 for Immediate Reportable Disease and Conditions Anthrax Escherichia coli: Shiga Toxin producing (STEC), Rabies (Specify Human or Animal) Botulism (Specify Infant, Foodborne, Wound, Other) including E. coli O157:H7 Scrombroid Fish Poisoning Brucellosis, Human Flavivirus Infection of Undetermined Species Shiga Toxin (Detected in Feces) Cholera Foodborne Disease (2 or More Cases) Smallpox (Variola) Ciguatera Fish Poisoning Hemolytic Uremic Syndrome Tularemia, human Dengue Virus Infection Influenza, Novel Strains, Human Viral Hemorrhagic Fever (Crimean-Congo, Ebola, Diphtheria Measles (Rubeola) Lassa, and Marburg Viruses) Domonic Acid Poisoning (Amnesic Shellfish Meningococcal Infections Yellow Fever Poisoning) Novel Virus Infection with Pandemic Potential Zika Virus Infection Paralytic Shellfish Poisoning Plague (Specify Human or Animal) Immediately report the occurrence of any unusual disease OR outbreaks of any disease. REPORT BY PHONE, FAX, MAIL WITHIN ONE (1) WORKING DAY Phone: (559) 852-2579 Fax: (559) 589-0482 Mail: 330 Campus Drive, Hanford 93230 Conditions may also be reported electronically via the California
    [Show full text]
  • Coexistence of Antibodies to Tick-Borne
    Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 98(3): 311-318, April 2003 311 Coexistence of Antibodies to Tick-borne Agents of Babesiosis and Lyme Borreliosis in Patients from Cotia County, State of São Paulo, Brazil Natalino Hajime Yoshinari/+, Milena Garcia Abrão, Virginia Lúcia Nazário Bonoldi, Cleber Oliveira Soares*, Claudio Roberto Madruga*, Alessandra Scofield**, Carlos Luis Massard**, Adivaldo Henrique da Fonseca** Laboratório de Investigação em Reumatologia (LIM-17), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Arnaldo 455, 3º andar, 01246-903 São Paulo, SP, Brasil *Embrapa Gado de Corte, Campo Grande, MS, Brasil **Universidade Federal Rural do Rio de Janeiro, Seropédica, RJ, Brasil This paper reports a case of coinfection caused by pathogens of Lyme disease and babesiosis in brothers. This was the first case of borreliosis in Brazil, acquired in Cotia County, State of São Paulo, Brazil. Both children had tick bite history, presented erythema migrans, fever, arthralgia, mialgia, and developed positive serology (ELISA and Western-blotting) directed to Borrelia burgdorferi G 39/40 and Babesia bovis antigens, mainly of IgM class antibodies, suggestive of acute disease. Also, high frequencies of antibodies to B. bovis was observed in a group of 59 Brazilian patients with Lyme borreliosis (25.4%), when compared with that obtained in a normal control group (10.2%) (chi-square = 5.6; p < 0.05). Interestingly, both children presented the highest titers for IgM antibodies directed to both infective diseases, among all patients with Lyme borreliosis. Key words: lyme borreliosis - lyme disease - spirochetosis - borreliosis - babesiosis - coinfection - tick-borne disease - Brazil Babesiosis is a tick-borne disease distributed world- The first case of babesiosis in a healthy person, with wide, caused by hemoprotozoans of the genus Babesia, intact spleen, was reported in 1969 in a woman from Nan- which infects wild and domestic animals, promoting eco- tucket Island (Massachusetts, USA)(Wester et al.
    [Show full text]
  • Bacterial Soft Tissue Infections Following Water Exposure
    CHAPTER 23 Bacterial Soft Tissue Infections Following Water Exposure Sara E. Lewis, DPM Devin W. Collins, BA Adam M. Bressler, MD INTRODUCTION to early generation penicillins and cephalosporins. Thus, standard treatments include fluoroquinolones (ciprofloxacin, Soft tissue infections following water exposure are relatively levofloxacin), third and fourth generation cephalosporins uncommon but can result in high morbidity and mortality. (ceftazidime, cefepime), or potentially trimethoprim-sulfa These infections can follow fresh, salt, and brackish water (4). However, due to the potential of emerging resistance exposure and most commonly occur secondary to trauma. seen in Aeromonas species, susceptibilities should always be Although there are numerous microorganisms that can performed and antibiotics adjusted accordingly (3). It is cause skin and soft tissue infections following water important to maintain a high index of suspicion for Aeromonas exposure, this article will focus on the 5 most common infections after water exposure in fresh and brackish water bacteria. The acronym used for these bacteria--AEEVM, and to start the patient on an appropriate empiric antibiotic refers to Aeromonas species, Edwardsiella tarda, Erysipelothrix regimen immediately. rhusiopathiae, Vibrio vulnificus, and Mycobacterium marinum. EDWARDSIELLA TARDA AEROMONAS Edwardsiella tarda is part of the Enterobacteriaceae family. Aeromonas species are gram-negative rods found worldwide in It is a motile, facultative anaerobic gram-negative rod fresh and brackish water (1-3). They have also been found in that can be found worldwide in pond water, mud, and contaminated drinking, surface, and polluted water sources the intestines of marine life and land animals (5). Risk (3). Aeromonas are usually non-lactose fermenting, oxidase factors for infection include water exposure, exposure positive facultative anaerobes.
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Actinomycosis of the Maxilla – in BRIEF • Actinomycosis Is a Supparative and Often Chronic Bacterial Infection Most PRACTICE Commonly Caused by Actinomyces Israelii
    Actinomycosis of the maxilla – IN BRIEF • Actinomycosis is a supparative and often chronic bacterial infection most PRACTICE commonly caused by Actinomyces israelii. a case report of a rare oral • Actinomycotic infections may mimic more common oral disease or present in similar way to malignant disease. infection presenting in • Treatment of actinomycosis involves surgical removal of the infected tissue and appropriate antibiotic therapy to general dental practice eliminate the infection. T. Crossman1 and J. Herold2 Actinomycosis is a suppurative and often chronic bacterial infection most commonly caused by Actinomyces israelii. It is rare in dental practice. In the case reported the patient presented to his general dental practitioner complaining of a loose upper denture. This was found to be due to an actinomycotic infection which had caused extensive destruction and sequestration of the maxillary and nasal bones and subsequent deviation of the nasal septum. INTRODUCTION of the nose, affecting a patient who Actinomycosis is a suppurative and often initially presented to his general den- chronic bacterial infection most com- tal practitioner complaining of a loose monly caused by Actinomyces israelii . upper denture. Several species have been isolated from the oral cavity of humans, including A. CASE REPORT israelii, A. viscosus, A. naeslundii and An 85-year-old Caucasian male was A. odontolyticus.1 As suggested by Cope referred to the oral and maxillofacial in 1938 the infection may be classifi ed department by his general dental prac- anatomically as cervicofacial, thoracic titioner (GDP) complaining of a loose Fig. 1 Patient at presentation showing bony sequestra bilaterally affecting the upper or abdominal.
    [Show full text]
  • Bacterial Infections Diseases Picture Cause Basic Lesion
    page: 117 Chapter 6: alphabetical Bacterial infections diseases picture cause basic lesion search contents print last screen viewed back next Bacterial infections diseases Impetigo page: 118 6.1 Impetigo alphabetical Bullous impetigo Bullae with cloudy contents, often surrounded by an erythematous halo. These bullae rupture easily picture and are rapidly replaced by extensive crusty patches. Bullous impetigo is classically caused by Staphylococcus aureus. cause basic lesion Basic Lesions: Bullae; Crusts Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Impetigo page: 119 alphabetical Non-bullous impetigo Erythematous patches covered by a yellowish crust. Lesions are most frequently around the mouth. picture Lesions around the nose are very characteristic and require prolonged treatment. ß-Haemolytic streptococcus is cause most frequently found in this type of impetigo. basic lesion Basic Lesions: Erythematous Macule; Crusts Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Ecthyma page: 120 6.2 Ecthyma alphabetical Slow and gradually deepening ulceration surmounted by a thick crust. The usual site of ecthyma are the legs. After healing there is a permanent scar. The pathogen is picture often a streptococcus. Ecthyma is very common in tropical countries. cause basic lesion Basic Lesions: Crusts; Ulcers Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Folliculitis page: 121 6.3 Folliculitis
    [Show full text]